Apr 3 |
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
Mar 16 |
Cipher Pharmaceuticals' (TSE:CPH) three-year earnings growth trails the 93% YoY shareholder returns
|
Mar 14 |
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
|
Mar 8 |
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
|
Jan 29 |
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
|
Jan 29 |
OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
|
Nov 24 |
Cipher Pharmaceuticals Announces Change of Auditor
|
Nov 15 |
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
|
Nov 15 |
Cipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insiders
|
Nov 9 |
Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023
|